"At Newcastle Private our focus is on providing world class quality healthcare to our patients, right here in the Hunter, conveniently co-located with John Hunter Hospital in New Lambton Heights."

During the past decade, Newcastle Private Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Newcastle Private Hospital" #1 sponsor was "Australasian Gastro-Intestinal Trials Group" with 4 trials, followed by "Clovis Oncology, Inc." with 2 trials sponsored, "ImmunoGen, Inc." with 2 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Newcastle Private Hospital" #1 collaborator was "Academic and Community Cancer Research United" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "Gynecologic Oncology Group" with 2 trials as a collaborator and "National Health and Medical Research Council, Australia" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Newcastle Private Hospital" are "Colorectal Cancer" (3 trials), "Fallopian Tube Cancer" (3 trials), "Ovarian Cancer" (3 trials), "Epithelial Ovarian Cancer" (2 trials) and "Gastro-Oesophageal Cancer" (2 trials). Many other conditions were trialed in "Newcastle Private Hospital" in a lesser frequency.

Most popular intervention types in "Newcastle Private Hospital" are "Drug" (14 trials), "Other" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (3 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Regorafenib" (2 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Newcastle Private Hospital" are 12 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Newcastle Private Hospital". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Newcastle Private Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Newcastle Private Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".